A small company developing a new shingles vaccine announced Monday that the venture capitalist Moncef Slaoui, who previously ran the U.S. government’s Operation Warp Speed Covid vaccine effort ...

The small biotech plans to go head-to-head with Shingrix with an assist from some former GSK execs, one being Operation Warp Speed’s chief scientific advisor Moncef Slaoui, Ph.D. Before advising ...

View Full Profile. Learn about our Editorial Policies. Moncef Slaoui, the former head of the US government’s COVID-19 vaccine initiative called Operation Warp Speed, has been fired from the Galvani ...

GlaxoSmithKline has fired its former research boss Moncef Slaoui from the board of Galvani Bioelectronics, a company it majority owns, after an internal investigation found he sexually harassed a ...

Moncef Slaoui has stepped down from positions at three more companies, shortly after being dismissed from a firm owned by GlaxoSmithKline for alleged sexual harassment. In the space of 24 hours ...

Some of the brains behind Shingrix’s success will be heading over to Curevo, with the company revealing that it is adding former GSK vaccine lead Moncef Slaoui to its board of directors.

Even though he is seen amongst the most praised doctors in terms of the COVID19 response in the US, leading the Operation Warp Speed vaccine effort as appointed by the ex-Trump administration ...

Curevo also announced Monday that Moncef Slaoui, a former longtime GlaxoSmithKline exec, has joined as board chair. Giovanni Mariggi, partner at Medixi, also joined the board, as well as Tal Zaks ...